Star Health and Allied Insurance Company Limited (NSE:STARHEALTH)
India
· Delayed Price · Currency is INR 395.00
+5.60 (1.44%)
May 14, 2025, 12:31 PM IST
NSE:STARHEALTH Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Premiums & Annuity Revenue | 148,222 | 129,383 | 112,616 | 98,092 | 46,266 | Upgrade
|
| Total Interest & Dividend Income | 12,790 | 9,996 | 8,233 | 6,305 | 4,138 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 844.74 | 112.35 | 1,623 | 99.26 | Upgrade
|
| Other Revenue | 109.2 | 18.17 | 38.6 | 13.71 | 3.21 | Upgrade
|
| Total Revenue | 161,122 | 140,242 | 121,000 | 106,034 | 50,506 | Upgrade
|
| Revenue Growth (YoY) | 14.89% | 15.90% | 14.12% | 109.94% | 1.48% | Upgrade
|
| Policy Benefits | 104,194 | 85,999 | 73,204 | 85,400 | 43,695 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 22,407 | 18,537 | 16,828 | 14,922 | 5,858 | Upgrade
|
| Selling, General & Administrative | 2,562 | 23,599 | 20,310 | 18,221 | 14,736 | Upgrade
|
| Provision for Bad Debts | 4.8 | 25.13 | 10.96 | 26.17 | 345.47 | Upgrade
|
| Other Operating Expenses | 6,423 | -17.67 | -9.44 | - | - | Upgrade
|
| Total Operating Expenses | 152,519 | 128,152 | 111,850 | 119,323 | 64,648 | Upgrade
|
| Operating Income | 8,602 | 12,090 | 9,150 | -13,289 | -14,141 | Upgrade
|
| Interest Expense | - | -801.39 | -884.19 | -720.06 | -283.66 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.3 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.1 | 2.15 | 0.41 | 56.72 | -0.6 | Upgrade
|
| EBT Excluding Unusual Items | 8,611 | 11,290 | 8,267 | -13,953 | -14,426 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -1.84 | -2.47 | -13.63 | -32.35 | Upgrade
|
| Pretax Income | 8,611 | 11,288 | 8,264 | -13,966 | -14,458 | Upgrade
|
| Income Tax Expense | 2,152 | 2,838 | 2,078 | -3,560 | -3,601 | Upgrade
|
| Net Income | 6,459 | 8,450 | 6,186 | -10,407 | -10,857 | Upgrade
|
| Net Income to Common | 6,459 | 8,450 | 6,186 | -10,407 | -10,857 | Upgrade
|
| Net Income Growth | -23.57% | 36.60% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 587 | 583 | 578 | 558 | 499 | Upgrade
|
| Shares Outstanding (Diluted) | 595 | 596 | 594 | 558 | 499 | Upgrade
|
| Shares Change (YoY) | -0.14% | 0.22% | 6.50% | 11.78% | 1.99% | Upgrade
|
| EPS (Basic) | 11.01 | 14.48 | 10.70 | -18.65 | -21.75 | Upgrade
|
| EPS (Diluted) | 10.86 | 14.19 | 10.41 | -18.65 | -21.75 | Upgrade
|
| EPS Growth | -23.47% | 36.31% | - | - | - | Upgrade
|
| Free Cash Flow | 12,959 | 11,865 | 12,292 | -75.67 | 8,443 | Upgrade
|
| Free Cash Flow Per Share | 21.79 | 19.92 | 20.68 | -0.14 | 16.91 | Upgrade
|
| Operating Margin | 5.34% | 8.62% | 7.56% | -12.53% | -28.00% | Upgrade
|
| Profit Margin | 4.01% | 6.02% | 5.11% | -9.81% | -21.50% | Upgrade
|
| Free Cash Flow Margin | 8.04% | 8.46% | 10.16% | -0.07% | 16.72% | Upgrade
|
| EBITDA | 8,832 | 12,319 | 9,671 | -12,856 | -13,684 | Upgrade
|
| EBITDA Margin | 5.48% | 8.78% | 7.99% | -12.13% | -27.09% | Upgrade
|
| D&A For EBITDA | 229.62 | 229.62 | 520.67 | 432.99 | 457.3 | Upgrade
|
| EBIT | 8,602 | 12,090 | 9,150 | -13,289 | -14,141 | Upgrade
|
| EBIT Margin | 5.34% | 8.62% | 7.56% | -12.53% | -28.00% | Upgrade
|
| Effective Tax Rate | 24.99% | 25.14% | 25.15% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.